CYTRX
Dead / Cancelled — Cancelled — Section 8 (as of 11 Dec 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85567155
- Registration number
- 4526276
- Mark type
- Stylized text
- Filed
- 12 Mar 2012
- Published for opposition
- 31 Jul 2012
- Registered
- 06 May 2014
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- CytRx Corporation, Los Angeles, CA, US
- CytRx Corporation, Los Angeles, CA, US
- CytRx Corporation, Los Angeles, CA, US
Prosecution history
- 11 Dec 2020 — CANCELLED SEC. 8 (6-YR)
- 06 May 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 May 2014 — REGISTERED-PRINCIPAL REGISTER
- 08 Apr 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Mar 2014 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Mar 2014 — USE AMENDMENT FILED
- 12 Mar 2014 — TEAS STATEMENT OF USE RECEIVED
- 25 Sept 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2013 — SOU EXTENSION 2 GRANTED
- 17 Sept 2013 — SOU EXTENSION 2 FILED
- 17 Sept 2013 — SOU TEAS EXTENSION RECEIVED
- 19 Jan 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jan 2013 — SOU EXTENSION 1 GRANTED
- 28 Dec 2012 — SOU EXTENSION 1 FILED